Liposomal doxorubicin-investigational chemotherapy-tissue Doppler imaging evaluation (LITE) randomized pilot study

Trial Profile

Liposomal doxorubicin-investigational chemotherapy-tissue Doppler imaging evaluation (LITE) randomized pilot study

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Antineoplastics; Cyclophosphamide; Docetaxel; Doxorubicin liposomal; Epirubicin; Fluorouracil
  • Indications Breast cancer
  • Focus Adverse reactions
  • Acronyms LITE
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 31 Aug 2011 Results presented at the ESC Congress 2011: Annual Congress of the European Society of Cardiology.
    • 12 May 2008 The expected completion date for this trial is now 1 Dec 2009, according to ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top